NCT04669899 2024-04-09Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid TumorsJounce Therapeutics, Inc.Phase 1/2 Completed190 enrolled
NCT02828098 2024-01-29Exploratory Study of BO-112 in Adult Patients With Aggressive Solid TumorsHighlight TherapeuticsPhase 1 Completed44 enrolled